Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A comparative analysis of cytochrome P450 activities in paired liver and small intestinal samples from patients with obesity.

Krogstad V, Peric A, Robertsen I, Kringen MK, Wegler C, Angeles PC, Hjelmesaeth J, Karlsson C, Andersson S, Artursson P, Asberg A, Andersson TB, Christensen H.

Drug Metab Dispos. 2019 Nov 4. pii: dmd.119.087940. doi: 10.1124/dmd.119.087940. [Epub ahead of print]

2.

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.

Bråten LS, Haslemo T, Jukic MM, Ingelman-Sundberg M, Molden E, Kringen MK.

Neuropsychopharmacology. 2019 Oct 24. doi: 10.1038/s41386-019-0554-x. [Epub ahead of print]

PMID:
31649299
3.

A girl of early school-age with no response to opioids during general anaesthesia.

Olsen TCR, Rasmussen AR, Kringen MK, Molden E.

Tidsskr Nor Laegeforen. 2019 Mar 31;139(7). doi: 10.4045/tidsskr.18.0561. Print 2019 Apr 9. Norwegian, English. No abstract available.

4.

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltrán L, Jiménez-Varo E, Cañadas-Garre M, Giontella A, Kringen MK, Haug KBF, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genç E, Özer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C.

Clin Pharmacol Ther. 2019 Jun;105(6):1477-1491. doi: 10.1002/cpt.1323. Epub 2019 Feb 17.

PMID:
30506689
5.

Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.

Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Høiseth G.

Ther Drug Monit. 2017 Oct;39(5):550-555. doi: 10.1097/FTD.0000000000000437.

PMID:
28723731
6.

Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women.

Reppe S, Lien TG, Hsu YH, Gautvik VT, Olstad OK, Yu R, Bakke HG, Lyle R, Kringen MK, Glad IK, Gautvik KM.

Epigenetics. 2017 Aug;12(8):674-687. doi: 10.1080/15592294.2017.1345832. Epub 2017 Jun 26.

7.

Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre.

Narum S, Brørs O, Stokland O, Kringen MK.

BMC Emerg Med. 2016 Aug 2;16(1):29. doi: 10.1186/s12873-016-0094-1.

8.

Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells.

Tekpli X, Urbanucci A, Hashim A, Vågbø CB, Lyle R, Kringen MK, Staff AC, Dybedal I, Mills IG, Klungland A, Staerk J.

Epigenetics Chromatin. 2016 May 31;9:21. doi: 10.1186/s13072-016-0070-8. eCollection 2016.

9.

Analysis of Copy Number Variation by Pyrosequencing® Using Paralogous Sequences.

Kringen MK.

Methods Mol Biol. 2015;1315:115-21. doi: 10.1007/978-1-4939-2715-9_9.

PMID:
26103895
10.

Copy number variation in the ATP-binding cassette transporter ABCC6 gene and ABCC6 pseudogenes in patients with pseudoxanthoma elasticum.

Kringen MK, Stormo C, Berg JP, Terry SF, Vocke CM, Rizvi S, Hendig D, Piehler AP.

Mol Genet Genomic Med. 2015 May;3(3):233-7. doi: 10.1002/mgg3.137. Epub 2015 Mar 8.

11.

RNA-sequencing analysis of HepG2 cells treated with atorvastatin.

Stormo C, Kringen MK, Lyle R, Olstad OK, Sachse D, Berg JP, Piehler AP.

PLoS One. 2014 Aug 25;9(8):e105836. doi: 10.1371/journal.pone.0105836. eCollection 2014.

12.

Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.

Kringen MK, Piehler AP, Grimholt RM, Opdal MS, Haug KB, Urdal P.

PLoS One. 2014 Feb 28;9(2):e90248. doi: 10.1371/journal.pone.0090248. eCollection 2014.

13.

UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone.

Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK.

Mol Diagn Ther. 2013 Aug;17(4):233-7. doi: 10.1007/s40291-013-0031-x.

PMID:
23580084
14.

Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system.

Narum S, Solhaug V, Myhr K, Brørs O, Kringen MK.

Eur J Clin Pharmacol. 2013 Jul;69(7):1445-52. doi: 10.1007/s00228-013-1479-7. Epub 2013 Feb 20.

PMID:
23423243
15.

Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.

Danese E, Montagnana M, Johnson JA, Rettie AE, Zambon CF, Lubitz SA, Suarez-Kurtz G, Cavallari LH, Zhao L, Huang M, Nakamura Y, Mushiroda T, Kringen MK, Borgiani P, Ciccacci C, Au NT, Langaee T, Siguret V, Loriot MA, Sagreiya H, Altman RB, Shahin MH, Scott SA, Khalifa SI, Chowbay B, Suriapranata IM, Teichert M, Stricker BH, Taljaard M, Botton MR, Zhang JE, Pirmohamed M, Zhang X, Carlquist JF, Horne BD, Lee MT, Pengo V, Guidi GC, Minuz P, Fava C.

Clin Pharmacol Ther. 2012 Dec;92(6):746-56. doi: 10.1038/clpt.2012.184. Epub 2012 Nov 7. Review.

16.

A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus.

Stormo C, Kringen MK, Grimholt RM, Berg JP, Piehler AP.

BMC Mol Biol. 2012 Sep 18;13:29. doi: 10.1186/1471-2199-13-29.

17.

Copy number variations of the ATP-binding cassette transporter ABCC6 gene and its pseudogenes.

Kringen MK, Stormo C, Grimholt RM, Berg JP, Piehler AP.

BMC Res Notes. 2012 Aug 9;5:425. doi: 10.1186/1756-0500-5-425.

18.

Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.

Evang JA, Berg JP, Casar-Borota O, Lekva T, Kringen MK, Ramm-Pettersen J, Bollerslev J.

Clin Endocrinol (Oxf). 2011 Dec;75(6):811-8. doi: 10.1111/j.1365-2265.2011.04109.x.

PMID:
21595730
19.

Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system.

Narum S, Solhaug V, Myhr K, Johansen PW, Brørs O, Kringen MK.

Br J Clin Pharmacol. 2011 Feb;71(2):254-62. doi: 10.1111/j.1365-2125.2010.03827.x.

20.

Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction.

Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O.

J Biomed Biotechnol. 2011;2011:739751. doi: 10.1155/2011/739751. Epub 2010 Nov 24.

21.

Reduced platelet function and role of drugs in acute gastrointestinal bleeding.

Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR.

Basic Clin Pharmacol Toxicol. 2011 Mar;108(3):194-201. doi: 10.1111/j.1742-7843.2010.00643.x. Epub 2010 Nov 30.

22.

No link between X chromosome inactivation pattern and simple goiter in females: evidence from a twin study.

Brix TH, Hansen PS, Knudsen GP, Kringen MK, Kyvik KO, Orstavik KH, Hegedüs L.

Thyroid. 2009 Feb;19(2):165-9. doi: 10.1089/thy.2008.0380.

PMID:
19191747
23.

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction.

Haug KBF, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O.

Thromb J. 2008 Jun 17;6:7. doi: 10.1186/1477-9560-6-7.

Supplemental Content

Loading ...
Support Center